Authors
Latest:
Fever of Unknown Origin: What Do We Know and Where Do We Go?As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
Latest:
The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic ArthritisA study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Latest:
Multidrug Resistance in a Patient With HIVIn this case study, clinicians review a challenging case.
Latest:
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVAt CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Latest:
340B Drug Pricing Program: What Is It and Why Is It Important?The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
Latest:
COVID-19 Convalescent Plasma: What Is Its Role in Therapy?The key is using the right dose on the right patient at the right time.
Latest:
Bringing MRSA Back to the ForefrontJeanine Thomas, president and founder of MRSA Survivors Network, talks about her personal battle with osteomyelitis, her work as an advocate, and the need for data and awareness to bring it to the forefront again.
Latest:
RSV Prophylaxis: Palivizumab, Nirsevimab, and MoreCurrent prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.
Latest:
A Rare Case of Positive Heterophile Antibody in a Patient With West Nile VirusThis unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.
Latest:
COVID-19 Booster Shots and the FutureKey opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Latest:
Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIVHere is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.
Latest:
High-Resistance Therapy Options for Treatment-Naïve Patients With HIVJoseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.
Latest:
An Update on the Pasteur ActAmanda Jezek, of the Infectious Diseases Society of America (IDSA), offers some insight on the prospective bill in Congress, as well as other AMR initiatives the organization is involved in.
Latest:
Case of Rabbit Fever Diagnosed in USThe first 2024 case of tularemia also known as rabbit fever was confirmed in a Wheat Ridge, Colorado resident.
Latest:
Fidaxomicin Reduces Recurrence Risk in High-Risk C difficile InfectionsAt MAD-ID, Alyssa Cox, PharmD, showed fidaxomicin reduces 90-day recurrence by 68.3% versus vancomycin, with rates of 7.9% vs. 19% in 176 hospitalized patients.
Latest:
Tuberculosis Meningitis in an Immunocompetent PatientRead more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
Latest:
Fidaxomicin Tied to Lower C difficile Recurrence in Immunocompromised PatientsPresented at MAD-ID 2025, Natt Patimavirujh, PharmD, supports fidaxomicin over vancomycin for high-risk groups, including transplant and chemotherapy patients.
Latest:
Oral Step-Down Therapy for Uncomplicated Streptococcal Bloodstream Infections: β-Lactams or Fluoroquinolones?An assessment of a comparative study between leading options for a burdensome infection.
Latest:
I Kidney Not: Antibiotic Dosing Strategies in Intermittent HemodialysisIn the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
Latest:
Resolution of Scurvy in a Patient With a Spinal Cord InjuryAt 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.
Latest:
Discussing Outpatient COVID-19 TreatmentsHere is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.
Latest:
The Future and Resources in HCV CareExpert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Latest:
Advancing Antimicrobial Development Through AIAkhila Kosaraju, MD, addresses overcoming key challenges in antibiotic development using AI, a nonprofit model, and supportive policies.
Latest:
Bioaccumulation of Drugs by Human Gut Bacteria Can Affect Drug AvailabilityA new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.
Latest:
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVAt CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Latest:
Novel Hepatitis B Vaccines Show Promise in Phase 1a Study: Safety and Immunogenicity Results for GS-2829 and GS-6779Therapeutic vaccines GS-2829 and GS-6779 demonstrate immune responses and strong safety profile, showing potential to contribute to global hepatitis B elimination efforts.
Latest:
Best Practices for Getting Young Clinicians into ResearchThis time of year means new trainees will begin their careers and are excited to take on research projects. However, they may have limited to no experience in this area. Here is an opportunity to give them structure and guidance when committing to longitudinal trainee research.
Latest:
Gender-Affirming Care in Persons Living With HIVGender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
Latest:
Antibiotic Heteroresistance: What Is It and How Does It Impact Patients?Low-frequency resistant cells in bacterial isolates are challenging to detect and may contribute to unexplained treatment failure.
